elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26745686-7B2AAE8C-5DEC-43B4-8DFC-96AAE2122BC2
Q26745686-7B2AAE8C-5DEC-43B4-8DFC-96AAE2122BC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745686-7B2AAE8C-5DEC-43B4-8DFC-96AAE2122BC2
Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy
P2860
Q26745686-7B2AAE8C-5DEC-43B4-8DFC-96AAE2122BC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745686-7B2AAE8C-5DEC-43B4-8DFC-96AAE2122BC2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
85c3e014ae7007ed37da756cc854389d51d4ff0a
a6fae09a7c4fc1b224b6583dfc13abffc38e1a06
P2860
ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex